Literature DB >> 25190432

Development and effect of different bioactive silicate glass scaffolds: in vitro evaluation for use as a bone drug delivery system.

Chidambaram Soundrapandian1, Arnab Mahato2, Biswanath Kundu3, Someswar Datta2, Biswanath Sa4, Debebrata Basu2.   

Abstract

Local drug delivery systems to bone have attracted appreciable attention due to their efficacy to improve drug delivery, healing and regeneration. In this paper, development and characterization of new formulations of bioactive glass into a porous scaffold has been reported for its suitability to act as a drug delivery system in the management of bone infections, in vitro. Two new glass compositions based on SiO2-Na2O-ZnO-CaO-MgO-P2O5 system (BGZ and MBG) have been developed which after thorough chemical and phase evaluation, studied for acellular static in vitro bioactivity in SBF. Porous scaffolds made of these glasses have been fabricated and characterized thoroughly for bioactivity study, SEM, XRD, in vitro cytotoxicity, MTT assay and wound healing assay using human osteocarcoma cells. Finally, gatifloxacin was loaded into the porous scaffold by vacuum infiltration method and in vitro drug release kinetics have been studied with varying parameters including dissolution medium (PBS and SBF) and with/without impregnation chitosan. Suitable model has also been proposed for the kinetics. 63-66% porous and 5-50μm almost unimodal porous MBG and BGZ bioactive glass scaffolds were capable of releasing drugs successfully for 43 days at concentrations to treat orthopedic infections. In addition, it was also observed that the release of drug followed Peppas-Korsmeyer release pattern based on Fickian diffusion, while 0.5-1% chitosan coating on the scaffolds decreased the burst release and overall release of drug. The results also indicated that MBG based scaffolds were bioactive, biocompatible, noncytotoxic and exhibited excellent wound healing potential while BGZ was mildly cytotoxic with moderate wound healing potential. These results strongly suggest that MBG scaffolds appear to be a suitable bone drug delivery system in orthopedic infections treatment and as bone void fillers, but BGZ should be handled with caution or studied elaborately in detail further to ascertain and confirm the cytotoxic nature and wound healing potential of this glass.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Acellular static in vitro bioactivity; Bioactive glass; Drug delivery system and model; MTT; Wound healing assay

Mesh:

Substances:

Year:  2014        PMID: 25190432     DOI: 10.1016/j.jmbbm.2014.08.007

Source DB:  PubMed          Journal:  J Mech Behav Biomed Mater        ISSN: 1878-0180


  3 in total

1.  Improved Mechanical Properties and Bioactivity of Silicate Based Bioceramics Reinforced Poly(ether-ether-ketone) Nanocomposites for Prosthetic Dental Implantology.

Authors:  Noha Taymour; Amal E Fahmy; Mohamed Abdel Hady Gepreel; Sherif Kandil; Ahmed Abd El-Fattah
Journal:  Polymers (Basel)       Date:  2022-04-18       Impact factor: 4.967

2.  Multifunctional zinc ion doped sol - gel derived mesoporous bioactive glass nanoparticles for biomedical applications.

Authors:  Zuzana Neščáková; Kai Zheng; Liliana Liverani; Qaisar Nawaz; Dagmar Galusková; Hana Kaňková; Martin Michálek; Dušan Galusek; Aldo R Boccaccini
Journal:  Bioact Mater       Date:  2019-10-27

3.  Chronic Osteomyelitis - Bacterial Flora, Antibiotic Sensitivity and Treatment Challenges.

Authors:  Kuzma Jerzy; Hombhanje Francis
Journal:  Open Orthop J       Date:  2018-03-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.